Lv0
0 积分 2023-06-18 加入
Presence of onco-fetal neighborhoods in hepatocellular carcinoma is associated with relapse and response to immunotherapy
17小时前
待确认
Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study
11天前
已完结
Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study
11天前
已完结
ECM1 attenuates hepatic fibrosis by interfering with mediators of latent TGF-β1 activation
29天前
已完结
Tertiary lymphoid structures in cancer
1个月前
已完结
Where Is the Future of Adjuvant Therapy for Hepatocellular Carcinoma?
1个月前
已完结
Personalized MRD Assessment in Peri-surgical ctDNA for Prognostic Prediction in Hepatocellular Carcinoma
1个月前
已完结
Early alpha‐foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma
1个月前
已完结
IRGM is a novel regulator of PD-L1 via promoting S6K1-mediated phosphorylation of YBX1 in hepatocellular carcinoma
4个月前
已完结
RBM12 drives PD-L1-mediated immune evasion in hepatocellular carcinoma by increasing JAK1 mRNA translation
4个月前
已完结
皖公网安备34019202002308
